Human Molecular GeneticsGeneticsPeer-reviewed journal article
Dominant monoallelic variant in the PAK2 gene causes Knobloch syndrome type 2
Stylianos E. AntonarakisiD, Aleš HoloubekiD, Melivoia RaptiiD, Jesse D. RademakeriD, Jenny Meylan, Justyna IwaszkiewicziD, Vincent ZoeteiD, Callum J. WilsoniD, Juliet P. TayloriD, Muhammad AnsariD, Christelle BoreliD, Olivier MenzeliD, Kateřina KuželováiD, Federico Andrea SantoniiD
Abstract
Knobloch syndrome is an autosomal recessive phenotype mainly characterized by retinal detachment and encephalocele caused by biallelic pathogenic variants in the COL18A1 gene. However, there are patients clinically diagnosed as Knobloch syndrome with unknown molecular etiology not linked to COL18A1. We studied an historical pedigree (published in 1998) designated as KNO2 (Knobloch type 2 syndrome with intellectual disability, autistic behavior, retinal degeneration, encephalocele). Whole exome sequencing of the two affected siblings and the normal parents resulted in the identification of a PAK2 non-synonymous substitution p.(Glu435Lys) as a causative variant. The variant was monoallelic and apparently de novo in both siblings indicating a likely germline mosaicism in one of the parents; the mosaicism however could not be observed after deep sequencing of blood parental DNA. PAK2 encodes a member of a small group of serine/threonine kinases; these P21-activating kinases (PAKs) are essential in signal transduction and cellular regulation (cytoskeletal dynamics, cell motility, death and survival signaling, and cell cycle progression). Structural analysis of the PAK2 p.(Glu435Lys) variant which is located in the kinase domain of the protein predicts a possible compromise in the kinase activity. Functional analysis of the p.(Glu435Lys) PAK2 variant in transfected HEK293T cells results in a partial loss of the kinase activity. PAK2 has been previously suggested as an autism related gene. Our results show that PAK2 induced phenotypic spectrum is broad and not fully understood. We conclude that the KNO2 syndrome in the studied family is dominant and caused by a deleterious variant in the PAK2 gene.
- organism: human
- assay: whole-exome sequencing
- research focus: variant calling
- research focus: variant effect prediction
- approach: experimental assay
- Citations
- 18
- FWCI
- 1.41
- Field percentile
- top 20%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A de novo variant in PAK2 detected in an individual with Knobloch type 2 syndrome
Elizabeth A. Werren, Louisa Kalsner, … Adam P. Matson·American Journal of Medical Genetics Part APeer-reviewed·Jan 28, 2025
- Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain
Felix Marbach, Georgi Stoyanov, … Elizabeth L. Fieg·Genetics in MedicinePeer-reviewed·Apr 8, 2021
- CK2 variant function and disease modelling in Drosophila reveal allelic heterogeneity and Wnt/β-catenin-mediated phenotypes
Yina Her, Danielle M. Pascual, … Paul C. Marcogliese·bioRxiv·Aug 21, 2026
- Germline mosaicism of a missense variant in KCNC2 in a multiplex family with autism and epilepsy
Elvisa Mehinovic, Teddi Gray, … Tychele N. Turner·American Journal of Medical Genetics Part APeer-reviewed·Apr 2, 2022
- Bi-allelic variants in CHKA cause a neurodevelopmental disorder with epilepsy and microcephaly
Chiara Klöckner, J. Pedro Fernández-Murray, … Konrad Platzer·BrainPeer-reviewed·Feb 21, 2022
- De novo EIF2AK1 and EIF2AK2 variants are associated with developmental delay, leukoencephalopathy, and neurologic decompensation
Dongxue Mao, Chloe M. Reuter, … Christine M. Eng·The American Journal of Human GeneticsPeer-reviewed·Mar 19, 2020